March 12 (Reuters) - MaxCyte Inc MXCT.O:
MAXCYTE INC - FY24 NET LOSS $41.1 MILLION VERSUS LOSS OF $37.9 MILLION IN 2023
MAXCYTE INC - SEES 2025 CORE REVENUE TO GROW 8% TO 15% COMPARED TO 2024
Source text: ID:nRSL2752Aa
Further company coverage: MXCT.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.